Dynamic contrast-enhanced (DCE) breast MRI is a highly sensitive modality for detecting breast cancer, but its limited specificity often leads to false-positive findings and unnecessary biopsies.

Current biotechnologies can simultaneously measure multiple high-dimensional modalities (e.g., RNA, DNA accessibility, and protein) from the same cells. A combination of different analytical tasks ...